Document Classification

Section Type: RESULTS

Text: Overall bleeding rates tended to be higher with atopaxar compared with placebo by CURE criteria (placebo, 0. 6 % ; atopaxar, 3. 9 % ; relative risk, 6. 82, P = 0. 03 ; 50 mg, 3. 9 % ; 100 mg, 1. 7 % ; 200 mg, 5. 9 % ; P for trend = 0. 01) and TIMI criteria (placebo, 6. 8 % ; atopaxar, 10. 3 % ; relative risk, 1. 52, P = 0. 17 ; 50 mg, 9. 9 % ; 100 mg, 8. 1 % ; 200 mg, 12. 9 % ; P for trend = 0. 07).